PHARMASEAL International Ltd, a technology provider of clinical trial management and governance solutions for biopharmaceutical, CROs and medical device organizations has today announced that it has entered into a partnership agreement with …
PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company
PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning US-based company providing ultrasound technology.
The Engility® Trial …
PHARMASEAL’s £1million crowdfunding campaign aimed at increasing clinical trial turnaround times gains momentum
A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone.
Launched by the new provider of clinical trial management and governance …
An Opportunity to Shape the Future of Clinical Trials: PHARMASEAL Launches £1 million Crowdfunding Campaign
PHARMASEAL, a new provider of clinical trial management and governance solutions, today announces the launch of a £1 million crowdfunding round with Seedrs.
The capital raised will enable the company to continue commercialisation and …
Engility®CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes
PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today that a leading US health outcomes and technology company has selected Engility® Clinical Trial Management system for the management and …
PHARMASEAL expands Engility® trial management platform with the addition of eTMF document storage
PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platform. Electronic trial master file (eTMF) document storage is now available alongside clinical …